Erlotinib intermediates manufacturer

Tel: +86-311-67260775
Your location: Home » Products > API

Regorafenib powder 755037-03-7 for Anti cancer Regorafenib Monohydrate


Regorafenib powder 755037-03-7 for Anti cancer Regorafenib Monohydrate

 Regorafenib is a multi-targeted multi-kinase inhibitor of tyrosine kinase. More than ten targets are targeted: VEGFR1, VEGFR2, VEGFR3, TIE-1, TIE-2, RAF-1, BRAF, BRAFV600, KIT, RET, PDGFR, FGFR and so on.


Regufenib is a multikinase inhibitor that inhibits tumor growth by inhibiting tumor angiogenesis, tumor cell renewal, and maintaining tumor microenvironment. Including VEGF receptors 1-3, KIT, PDGFR-alpha, PDGFR-beta, RET, FGFR1 and 2, TIE2, DDR2, TrkA, Eph2A, RAF-1, BRAF, BRAF-V600E, SAPK2, PTK5 and Abl.


Regorafenib is a kinase inhibitor that has been used previously for fluoropyrimidine-based, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF treatment, an anti-EGFR-treated metastasis Treatment of colorectal cancer (CRC) patients.


Send your message to us
(* We will reply your inquiry to this Email as soon as we see it.)
Name: *
E-mail: *
Message: *
Verification Code: *图片看不清?点击重新得到验证码
Other Products
Office Address: No.41, Zhaiying South Street, Yuhua District, Shijiazhuang, Hebei Province.Chinaa
R&D and Plant Address: Jinzhou Industry Park, Jinzhou County, Shijizhuang, Hebei Province.China
Tel: +86-311-67260775
Fax: +86-311-67591193
Online Service×